ARMP
AMEX · Biotechnology
Armata Pharmaceuticals Inc
$8.05
-0.15 (-1.83%)
Open$8.20
Previous Close$8.20
Day High$8.61
Day Low$7.50
52W High$16.34
52W Low$1.17
Volume—
Avg Volume77.1K
Market Cap295.52M
P/E Ratio—
EPS$-4.79
SectorBiotechnology
Analyst Ratings
Strong Buy
8 analysts
Price Target
+116.8% upside
Current
$8.05
$8.05
Target
$17.45
$17.45
$10.78
$17.45 avg
$19.60
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 4.44M | 4.62M | 51.72M |
| Net Income | -157,477,106 | -147,343,170 | -16,237,176 |
| Profit Margin | -3,544.0% | -3,366.8% | -31.4% |
| EBITDA | -31,804,734 | -31,411,266 | -19,844,642 |
| Free Cash Flow | — | — | -12,228,215 |
| Rev Growth | -3.8% | -3.8% | -2.8% |
| Debt/Equity | — | — | 1.13 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $213.76 | +2.08% | 88.1 | 372.39B |
| AMGN | Amgen Inc | $330.33 | -0.13% | 23.0 | 179.23B |
| GILD | Gilead Sciences Inc | $130.28 | -0.17% | 17.4 | 160.50B |
| VRTX | Vertex Pharmaceuticals Inc | $429.32 | -1.15% | 26.4 | 114.32B |
| REGN | Regeneron Pharmaceuticals | $641.69 | +1.81% | 16.7 | 73.89B |
| ALNY | Alnylam Pharmaceuticals Inc | $293.86 | -0.15% | 66.6 | 38.43B |